At diabetes clinics across India, discussions increasingly focus on expenses rather than dietary concerns or exercise regimes. The price of medications like Ozempic, known for their effectiveness, has often restrained many patients from pursuing these innovative...
The Indian healthcare market is bracing for a significant change as more than twenty generic variants of semaglutide, a highly sought-after drug for obesity and diabetes, are set to be introduced in the coming weeks. This...
